Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Clinical Study of the Fortilink-TS Ti

NCT07834736 is registered in ClinicalTrials.gov with BAAT Medical Products B.V. as lead sponsor.

NCT NCT07834736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07834736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Clinical Study of the Fortilink-TS Ti
Lead sponsor
BAAT Medical Products B.V.
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2026
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease lumbar, spondylolisthesis, grade 1